Micropaque Ct (Barium Sulfate)

Barium sulfate consists of insoluble, high‑density particles that remain within the gastrointestinal lumen after oral or rectal administration. The particles strongly attenuate X‑ray photons, creating a radiopaque coating that highlights the shape and lining of the GI tract, thereby improving image contrast during fluoroscopy or plain radiography.

The dose of Micropaque Ct is individualized by the prescribing physician based on the specific imaging study, patient age, weight, and clinical indication. The healthcare provider determines the appropriate volume and concentration required to obtain optimal radiographic images.

Safety of Micropaque Ct in pregnancy and lactation has not been definitively established. It should be used only if the diagnostic benefit outweighs potential risks, and the decision should be made by the treating physician in consultation with the patient.

To order Micropaque Ct, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Micropaque Ct (barium sulfate) provides superior mucosal coating for gastrointestinal imaging, whereas iodinated agents are water‑soluble and used for vascular or soft‑tissue studies. Barium offers higher radiopacity for GI lumen visualization but cannot be used intravascularly, while iodinated contrast can be administered intravenously for CT or angiography.

Micropaque Ct should be stored at ambient temperature below 25 °C, in its original container, protected from moisture and direct sunlight. Ensure the seal remains intact to maintain product stability and prevent contamination.

Micropaque Ct is administered orally as a suspension or via rectal enema, depending on the specific gastrointestinal study. The preparation is mixed with water or a suitable vehicle as instructed by the radiology team, and the patient is positioned to allow optimal coating of the target GI segment.

Serious risks include allergic reactions such as anaphylaxis, aspiration pneumonitis if the suspension is inhaled, bowel obstruction or perforation in patients with existing strictures, and severe constipation leading to impaction. Immediate medical attention is required if any of these events occur.

Micropaque Ct is contraindicated in patients with known hypersensitivity to barium sulfate, suspected or confirmed gastrointestinal obstruction, perforation, or severe constipation. Caution is also advised for individuals with dysphagia or impaired swallowing, as they are at higher risk of aspiration.